BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lete I, Obispo C, Izaguirre F, Orte T, Rivero B, Cornellana MJ, Bermejo I, on behalf of the Spanish Society of. The levonorgestrel intrauterine system (Mirena®) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction. The European Journal of Contraception & Reproductive Health Care 2009;13:231-7. [DOI: 10.1080/13625180802075075] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Blumenthal PD, Dawson L, Hurskainen R. Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system. Int J Gynaecol Obstet 2011;112:171-8. [PMID: 21269626 DOI: 10.1016/j.ijgo.2010.08.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
2 Shaw V, Vandal AC, Coomarasamy C, Ekeroma AJ. The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding. Aust N Z J Obstet Gynaecol 2016;56:619-23. [DOI: 10.1111/ajo.12528] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Lete I, Cristóbal I, Febrer L, Crespo C, Arbat A, Hernández FJ, Brosa M. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain. Eur J Obstet Gynecol Reprod Biol 2011;154:71-80. [PMID: 20951492 DOI: 10.1016/j.ejogrb.2010.08.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lete I, del Carme Cuesta M, Marín JM, Martínez M, Bermejo A, Arina R. Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device? Eur J Obstet Gynecol Reprod Biol 2011;154:67-70. [PMID: 20728261 DOI: 10.1016/j.ejogrb.2010.07.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
5 Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780-817. [PMID: 31770441 DOI: 10.1182/bloodadvances.2019000812] [Cited by in Crossref: 154] [Cited by in F6Publishing: 150] [Article Influence: 77.0] [Reference Citation Analysis]
6 Socolov D, Blidaru I, Tamba B, Miron N, Boiculese L, Socolov R. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma. The European Journal of Contraception & Reproductive Health Care 2011;16:480-7. [DOI: 10.3109/13625187.2011.614028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Jin XX, Sun L, Lai XL, Li J, Liang ML, Ma X. Effect of Mirena placement on reproductive hormone levels at different time intervals after artificial abortion. World J Clin Cases 2022; 10(2): 511-517 [DOI: 10.12998/wjcc.v10.i2.511] [Reference Citation Analysis]
8 Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168-186. [PMID: 19846889 DOI: 10.1182/blood-2009-06-225565] [Cited by in Crossref: 1177] [Cited by in F6Publishing: 929] [Article Influence: 90.5] [Reference Citation Analysis]
9 Hardman SM, Gebbie AE. Hormonal contraceptive regimens in the perimenopause. Maturitas 2009;63:204-12. [PMID: 19524378 DOI: 10.1016/j.maturitas.2009.05.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
10 Henry C, Ekeroma A, Dowell A, Filoche S. 'The horror stories put me off!': exploring women's acceptability of the Levonorgestrel IntraUterine System (LNG-IUS) for endometrial protection. J Prim Health Care 2021;13:55-62. [PMID: 33785111 DOI: 10.1071/HC20105] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 van Dijk MM, van Hanegem N, de Lange ME, Timmermans A. Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy? J Minim Invasive Gynecol 2015;22:1153-62. [PMID: 26151760 DOI: 10.1016/j.jmig.2015.06.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
12 Bürger Z, Bucher AM, Comasco E, Henes M, Hübner S, Kogler L, Derntl B. Association of levonorgestrel intrauterine devices with stress reactivity, mental health, quality of life and sexual functioning: A systematic review. Front Neuroendocrinol 2021;63:100943. [PMID: 34425187 DOI: 10.1016/j.yfrne.2021.100943] [Reference Citation Analysis]
13 Davidson BR, Dipiero CM, Govoni KD, Littleton SS, Neal JL. Abnormal Uterine Bleeding During the Reproductive Years. Journal of Midwifery & Women's Health 2012;57:248-54. [DOI: 10.1111/j.1542-2011.2012.00178.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Cristobal I, Lete LI, Viuda E, Perulero N, Arbat A, Canals I. One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users. Contraception 2016;93:367-71. [PMID: 26764120 DOI: 10.1016/j.contraception.2015.12.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
15 Bastianelli C, Farris M, Benagiano G. Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center. Contraception 2011;84:402-8. [PMID: 21920196 DOI: 10.1016/j.contraception.2011.01.020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]